Andrew Perlman
Direttore/Membro del Consiglio presso ARCUS BIOSCIENCES, INC.
Patrimonio netto: 441 928 $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Terry Rosen | M | 65 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 21 anni |
| David Collier | M | 61 |
Velocity Pharmaceutical Development LLC
 Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA.
X-37 Service Co., Inc.
 X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA. | 13 anni |
| Juan Jaen | M | 66 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 18 anni |
| Yasunori Kaneko | M | 69 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 16 anni |
| Corinne Nevinny | F | 64 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA.
Avestria Ventures Management, LLC
 Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | 12 anni |
| Ed F. Schnipper | M | 75 |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA.
Spitfire Pharma, Inc.
 Spitfire Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Spitfire Pharma, Inc. provides drug development and research services. The firm’s products include SP-1373, a potent GLP-1/Glucagon receptor co-agonist for the treatment of non-alcoholic steatohepatitis. The company was founded by John J. Nestor, Jr. and is headquartered in South San Francisco, CA. | 13 anni |
| Robert Goeltz | M | 51 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 7 anni |
| Jennifer Jarrett | F | 53 | 7 anni | |
| Nicole Lambert | F | 50 | 3 anni | |
| Alexander Azoy | M | 48 | 4 anni | |
| David Lacey | M | 71 | 4 anni | |
| Kathryn Falberg | F | 63 | 7 anni | |
| Clarence Machado | M | 60 | 5 anni | |
| Jim W. Larrick | M | - |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | 13 anni |
| Margot Shapiro | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | 2 anni |
| Linda Greub | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Steve Young | M | 55 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 12 anni |
| Antoni Ribas | M | 58 | 5 anni | |
| Carolyn Tang | F | 45 | 7 anni | |
| Dimitry Nuyten | M | 48 | 2 anni | |
| Eric Matthews | M | - | 5 anni | |
| Phyllis Gardner | M | 73 |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Tracy Dooley | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | 5 anni |
| Michelle Branch | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Mindy Goldman | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | 5 anni |
| Holli Kolkey | M | - | - | |
| Eva Epker | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | 5 anni |
| Jennifer Koski | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Susan Knowles | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Chimene Liburd | M | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Karol Watson | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Johanna Mercier | F | 54 | - | |
| Kiersten Stead | M | - |
X-37 Service Co., Inc.
X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA. | - |
| Bart Epker | M | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Yvonne Gehring | F | - | 8 anni | |
| Jonathan Yingling | M | 55 | 4 anni | |
| Abraham Heifets | M | - |
X-37 Service Co., Inc.
X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA. | - |
| Karen Richards | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| David Gluckman | M | - |
X-37 Service Co., Inc.
X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA. | 4 anni |
| Merdad Parsey | M | 61 | 4 anni | |
| Linda Higgins | M | 62 | 3 anni | |
| Antoine Blondeau | M | - |
X-37 Service Co., Inc.
X-37 Service Co., Inc. Miscellaneous Commercial ServicesCommercial Services X-37 Service Co., Inc. operates as a pharmaceutical discovery and development company. The firm uses advanced artificial intelligence technology to discover novel drug candidates by screening vast libraries of chemical compounds against pharmaceutical targets. It offers five development programs in areas of high medical need including cancer, autoimmune diseases, and coagulation disorders. The company was founded by David J. Collier and is headquartered in South San Francisco, CA. | - |
| James Watson | M | - |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | - |
| Karen Talmadge | M | 71 |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | - |
| Sharon Fay | F | 63 |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Elizabeth Weatherman | F | 64 |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
| Wayne I. Roe | M | 73 |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | - |
| Samuel Saks | M | 69 |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | 13 anni |
| Elisa Zhang | F | - |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| William Rieflin | M | 64 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 8 anni |
| David Goeddel | M | 72 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 13 anni |
| Steven McKnight | M | 75 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 13 anni |
| James M. Gower | M | 75 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 4 anni |
| Carla Daniel | F | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 6 anni |
| Michael Quigley | M | 42 | - | |
| Melissa C. Paoloni | M | - | 4 anni | |
| Brett Cummings | M | - |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | 8 anni |
| Daniel J. Levitt | M | 76 | 1 anni | |
| Stuart D. Sedlack | M | - |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | - |
| Hui Tian | M | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 5 anni |
| Nick Giafis | M | - | 3 anni | |
| Kartik Krishnan | M | - | 3 anni | |
| William Grossman | M | 54 | 2 anni | |
| Chris Smith | M | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | - |
| Julia C. Owens | M | 51 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 5 anni |
| Jean-Frédéric Viret | M | 58 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 anni |
| Stephen Shuttleworth | M | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 3 anni |
| Valerie Pierce | F | 61 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 4 anni |
| Karl G. Trass | M | 64 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 anni |
| Robert J. Stagg | M | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 anni |
| Patrick Baeuerle | M | 66 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 anni |
| Mike Rothe | M | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 5 anni |
| Camille Samuels | F | 52 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 anni |
| Marshall P. Levine | M | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 1 anni |
| John McLaughlin | M | 72 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 anni |
| Craig Saxton | M | 81 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 3 anni |
| Casey C. Case | M | - |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 4 anni |
| Pieter B. M. W. M. Timmermans | M | 74 |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 7 anni |
| Patricia Carlos | F | - | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 79 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Andrew Perlman
- Contatti personali
